In most US states, yes, you can refuse the vitamin K shot for your newborn. As of 2020, New York was the only state with a government mandate requiring the injection for all newborns. In every other state, parents can decline it, though hospitals will typically ask you to sign a waiver acknowledging the risks. That said, understanding what the shot prevents and what refusal means for your baby is critical before making that decision.
Why Newborns Need Vitamin K
Babies are born with very little vitamin K, the nutrient that allows blood to clot properly. The placenta transfers it poorly, with vitamin K levels in umbilical cord blood measuring less than 0.1 nmol/L, roughly 20 to 40 times lower than the mother’s blood levels. After birth, breast milk doesn’t close the gap: human milk contains a median of about 2.5 micrograms per liter of vitamin K, compared to 24 to 175 micrograms per liter in formula. This means exclusively breastfed babies who don’t receive supplementation remain at the highest risk for weeks to months.
Without adequate vitamin K, a baby can develop vitamin K deficiency bleeding (VKDB), a condition where blood doesn’t clot normally. This can cause bleeding in the skin, the gut, or the brain.
How Common and Serious Is VKDB
VKDB comes in three forms depending on timing. Early and classical forms appear in the first week of life and affect roughly 1 in 60 to 1 in 250 newborns who don’t receive prophylaxis. Late-onset VKDB is rarer, occurring in 1 in 14,000 to 1 in 25,000 infants, but it’s far more dangerous. It strikes between 1 week and 6 months of age, peaking between weeks 2 and 8, and up to 50% of late-onset cases involve bleeding inside the brain. It commonly presents with vomiting and seizures.
Infants who do not receive the vitamin K shot are 81 times more likely to develop late-onset VKDB than those who do. That’s a striking difference for a single injection given in the first hours of life.
What Happens If You Refuse
Outside of New York, refusing the shot is legal but not without process. Most hospitals will ask you to have a detailed conversation with a pediatrician or nurse about the risks, then sign a written refusal or informed consent waiver. This documents that you understood the potential consequences. In rare and extreme situations, particularly if a baby later develops unexplained bleeding, a refusal could trigger questions from child protective services, though this is uncommon.
Your baby’s medical record will note the refusal, and pediatricians at follow-up visits may raise the topic again, especially if your baby is exclusively breastfed.
The Leukemia Concern Has Been Thoroughly Studied
One of the most persistent reasons parents hesitate traces back to a 1992 study that suggested a link between the vitamin K injection and childhood leukemia. That finding prompted extensive research across multiple countries over the following decade. A pooled analysis of six major studies concluded there was “no convincing evidence” that the injection increases the risk of leukemia or any other cancer. The original finding is now widely attributed to statistical chance. Every major pediatric organization considers the injection safe.
What’s in the Injection
The shot contains phytonadione, which is simply the pharmaceutical name for vitamin K1, the same form found naturally in leafy green vegetables. The newborn dose is 1 mg, delivered in half a milliliter of liquid. The other ingredients include a castor oil derivative that helps the vitamin K dissolve in water, a small amount of dextrose (sugar), and benzyl alcohol as a preservative. Some parents express concern about benzyl alcohol, but the amount in a single half-milliliter dose is extremely small, well below levels associated with any toxicity.
Oral Vitamin K as an Alternative
Some parents ask about giving vitamin K by mouth instead of injection. Several European countries use oral regimens, but the results are notably less reliable. Oral vitamin K appears effective at preventing early and classical VKDB, but it performs poorly against late-onset VKDB, the most dangerous form. One reason is that oral regimens require multiple doses over weeks, and adherence drops sharply. A UK study found that compliance with a 3-dose oral regimen fell to 88% at 1 week and just 39% at 6 weeks. Even a weekly dosing schedule over 3 months, studied in Denmark, achieved only 86% to 94% adherence.
Countries that use oral prophylaxis consistently report more cases of late-onset VKDB than those using the injection. The American Academy of Pediatrics has recommended the intramuscular injection since 1961 and reaffirmed it in both 2003 and 2022, noting that oral dosing “compares poorly to the efficacy of IM vitamin K prophylaxis.” No standardized oral regimen is approved or recommended in the United States.
Risk Factors That Raise the Stakes
Certain babies face higher risk if they don’t receive the shot. Exclusively breastfed infants top the list because of the low vitamin K content in breast milk. Babies whose mothers took seizure medications or the antibiotic isoniazid during pregnancy are also at elevated risk, because these drugs interfere with vitamin K metabolism. Infants with undiagnosed liver or gallbladder problems that impair fat absorption (vitamin K is fat-soluble) can develop VKDB even weeks after birth, when parents may have stopped thinking about the decision they made in the delivery room.
Late-onset VKDB is particularly cruel in this regard. A baby can seem perfectly healthy for weeks before suddenly developing life-threatening bleeding, often in the brain, with little warning. By the time symptoms appear, significant damage may already be underway.